353: Trump's drug-pricing plan and a potential Theranos 2.0
The Readout Loud
00:00
Navigating Biotech Challenges
This chapter examines the current state of biotech stocks amidst market fluctuations, highlighting funding concerns and inflation impacts. It explores challenging decisions facing struggling companies and suggests a cautious optimism for sector recovery through potential consolidation.
Transcript
Play full episode
